Overview

26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation

Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Efficacy and Safety Trial of elobixibat in Patients with Chronic Idiopathic Constipation treated for 26 Weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Ferring Pharmaceuticals